Papers

1

Total Citations

3

H-Index

1

About

Runchen Wang is a pioneering thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer treatment. His most notable contribution is the development and validation of single-port robotic-assisted lobectomy and segmentectomy, a novel approach that reduces surgical trauma while maintaining oncologic efficacy. In his landmark 2025 paper, Wang demonstrated the safety and feasibility of this technique, establishing a new paradigm in robotic thoracic surgery. Though early in its citation impact, this work has already garnered significant attention, reflecting its potential to reshape surgical standards. Wang’s research addresses critical challenges in lung cancer management, including improving postoperative recovery and expanding access to robotic surgery. His achievements highlight a commitment to innovation at the intersection of robotics and oncology, positioning him as a rising leader in the field. For students and researchers, Wang’s work exemplifies how translational research can bridge cutting-edge technology and clinical practice, offering a roadmap for future advancements in surgical oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Safety and Feasibility of Novel Single-Port Robotic-Assisted Lobectomy/Segmentectomy for Lung Cancer
3 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: First Affiliated Hospital of Guangzhou Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago